{
"id":"mk19_a_id_t49",
"number":49,
"bookId":"id",
"title":{
"__html":"Treatment of Recurrent <i>Clostridioides difficile</i> Infection"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"68a1f8",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 49. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t49"
}
]
},
"Treatment of Recurrent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Clostridioides difficile"
]
},
" Infection"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cc2af7",
"class":"cell txt l",
"children":[
"First recurrence/second episode"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f4cde",
"class":"cell txt l",
"children":[
"Preferred: Fidaxomicin, 200 mg twice daily PO × 10 d OR twice daily for 5 days followed by once every other day for 20 days"
]
},
" ",
{
"type":"p",
"hlId":"fb7483",
"class":"cell txt l",
"children":[
"Alternative: Vancomycin, 125 mg four times daily PO × 10-14 d, then twice daily PO × 7 d, then once daily for 7 d, then every 2-3 d for 2-8 wk ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
}
]
},
" ",
{
"type":"p",
"hlId":"b3afe9",
"class":"cell txt l",
"children":[
"Alternative: Vancomycin, 125 mg four times daily PO × 10 d"
]
},
" ",
{
"type":"p",
"hlId":"3787e5",
"class":"cell txt l",
"children":[
"Adjunctive: Bezlotoxumab, 10 mg/kg IV once during standard antibiotic treatment in adults who have a recurrence within 6 months of a previous episode",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf0fb9",
"class":"cell txt l",
"children":[
"Second and subsequent recurrence(s)/third and subsequent episodes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f4cde",
"class":"cell txt l",
"children":[
"Preferred: Fidaxomicin, 200 mg twice daily PO × 10 d OR twice daily for 5 days followed by once every other day for 20 days"
]
},
" ",
{
"type":"p",
"hlId":"6d8f2d",
"class":"cell txt l",
"children":[
"Vancomycin, 125 mg four times daily PO × 10-14 d, then twice daily PO × 7 d, then once daily for 7 d, then every 2-3 d for 2-8 wk ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
}
]
},
" ",
{
"type":"p",
"hlId":"501ddf",
"class":"cell txt l",
"children":[
"Vancomycin, 125 mg four times daily PO × 10 d, followed by rifaximin, 400 mg three times daily PO × 20 d ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
}
]
},
" ",
{
"type":"p",
"hlId":"dbee71",
"class":"cell txt l",
"children":[
"Fecal microbiota transplantation"
]
},
" ",
{
"type":"p",
"hlId":"5d602d",
"class":"cell txt l",
"children":[
"Adjunctive: Bezlotoxumab, 10 mg/kg IV once during standard antibiotic treatment in adults who have a recurrence within 6 months of a previous episode",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"IV = intravenous; PO = by mouth."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Data when combined with fidaxomicin are limited. Use is cautioned in patients with congestive heart failure."
]
]
}